MGC is among the largest domestic market-focused CDMOs on a revenue basis serving IPM, with a market share of 9.3% by value in FY23 in the total addressable Indian domestic CDMO market and 8.8% by volume in the total IPM market in FY23. In the domestic CDMO market, the company had a market share of 29.4% by value in FY23, which increased from 26.7% in FY21. With creme-de-la-creme of dedicated pharmaceutical personnel and standardized practices, Akums has been successful in attaining national and international accreditations and building trust on Efficacy, Safety & Quality. The organization is certified with WHO-GMP, ISO 9001:2015, ISO 14001:2015, ISO 50001:2018, ISO 45001:2018, and ISO 22000:2018 certificates and various international accreditations, like; FDA Philippines, NMPB Sudan, NDA Uganda, Cambodia, Indonesia, Nigeria, Malawi amongst others.
Our Mission
To dedicate ourselves for humanity’s quest for longer, healthier and happier lives, through innovative healthcare products
Our Vision
To become a globally admired Pharmaceutical Organisation by providing research based, affordable quality products for larger global population.
Integrity:
We are committed to conducting ourselves with uncompromising integrity, honesty and ethical standards in all our operations and behavior
Respect:
We are committed to create environment that encourages diverse perspectives and upholds the dignity of work and individuals at all levels
Safety:
We are committed to conduct our business operations by practicing all safety norms and standards.
Sustainability:
We are committed to the value for all our stakeholders in a manner that respects our natural environment and serves best interests of the communities which we live and work.